The findings are based on data from 82,091 respondents to the National Health and Nutrition Examination Survey over the 15-year period. The survey looked at medications used in the past 30 days and the duration of use. Researchers characterized use of benzodiazepine and non-benzodiazepine hypnotics as short-, medium-, and long-term.
Between 1999 and 2014, the increase in benzodiazepine and non-benzodiazepine use was driven mainly by hikes in medium- and long-term use, according to the study, even after researchers adjusted for age and race-ethnicity.
According to a Psychiatric News Alert report on the study:
“Monitoring of use is needed to prevent adverse outcomes,” researchers wrote.
“Promoting the availability of behavioral sleep treatments may help reduce the need for pharmacological sleep interventions,” Psychiatric News Alert quoted from the study, “because sleep problems remain a major reason for their long-term use.”